Trial Profile
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2018
Price :
$35
*
At a glance
- Drugs Fluorine 18 THK 5351 (Primary)
- Indications Alzheimer's disease; Diabetes mellitus
- Focus Diagnostic use
- Acronyms TAUPET
- 27 Dec 2017 Planned initiation date changed from 1 Jun 2017 to 1 Dec 2017.
- 27 Dec 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 17 Apr 2017 Planned initiation date changed from 1 Feb 2017 to 1 Jun 2017.